In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
Jaebok Choi(Washington University in St. Louis), John F. DiPersio(Washington University in St. Louis), David Piwnica‐Worms(The University of Texas MD Anderson Cancer Center), Julie L. Prior(Imaging Center), William D. Shannon(Washington University in St. Louis), Elena Deych, Matthew Holt, Julie Ritchey
Cited by 306
Related Papers
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
|Immunity|2007|988
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
|Cancer Research|2012|941
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
|Cancer Research|2004|717